Sugi Predict

Sugi Predict / Compounds / SCHEMBL309490

SCHEMBL309490

SCHEMBL309490

CC(=O)OCC(C)C1CC=C(C)CC1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.39
▸ CYP3A4 P08684 2/20 0.39
▸ ALOX15 P16050 2/20 0.39
▸ NPC1 O15118 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ TAS2R46 P59540 2/20 0.34
▸ TRPM7 Q96QT4 1/20 0.34
▸ PTPN1 P18031 4/20 0.34
▸ MEN1 O00255 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ CHRNA7 P36544 1/20 0.33
▸ STAT3 P40763 1/20 0.33
▸ DHCR24 Q15392 2/20 0.31
▸ HCRTR2 O43614 1/20 0.30
▸ PPARG P37231 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18513494 0.86 TSHR (0.44) LMNACYP3A4ALOX15NPC1ALDH1A1
SCHEMBL17204124 0.86 TSHR (0.44) LMNACYP3A4ALOX15NPC1ALDH1A1
SCHEMBL14764011 0.86 ALDH1A1 (0.36) LMNACYP3A4ALOX15NPC1ALDH1A1
SCHEMBL18492269 0.83 TSHR (0.44) LMNACYP3A4ALOX15NPC1ALDH1A1
SCHEMBL17213211 0.83 TSHR (0.44) LMNACYP3A4ALOX15NPC1ALDH1A1
SCHEMBL18513491 0.83 TSHR (0.44) LMNACYP3A4ALOX15NPC1ALDH1A1
SCHEMBL18503897 0.81 LMNA (0.36) LMNACYP3A4ALOX15NPC1ALDH1A1
SCHEMBL2446522 0.80 LMNA (0.41) LMNACYP3A4ALOX15NPC1ALDH1A1
SCHEMBL14330244 0.80 LMNA (0.36) LMNACYP3A4ALOX15NPC1ALDH1A1
SCHEMBL4877806 0.78 LMNA (0.41) LMNACYP3A4ALOX15NPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240306688-A1 METHOD OF MITIGATING OFF-ODORS GIVAUDAN SA (CH) 2024-09-19 — — US claimed
EP-4391827-A1 METHOD OF MITIGATING OFF-ODORS Givaudan SA (CH) 2024-07-03 — — EP claimed
WO-2023025549-A1 METHOD OF MITIGATING OFF-ODORS GIVAUDAN SA (CH) 2023-03-02 — — WO claimed
CN-119584860-A Comprising biodegradable microcapsule composition 奇华顿股份有限公司 2025-03-07 — — CN disclosed
US-20240306688-A1 METHOD OF MITIGATING OFF-ODORS GIVAUDAN SA (CH) 2024-09-19 — — US disclosed
EP-4391827-A1 METHOD OF MITIGATING OFF-ODORS Givaudan SA (CH) 2024-07-03 — — EP disclosed
US-20240108040-A1 HIGH INTENSITY SWEETENERS FIRMENICH INCORPORATED (US) 2024-04-04 — — US disclosed
EP-3416729-B1 PRO-FRAGRANCE COMPOSITION AQDOT LTD (GB) 2023-09-20 — — EP disclosed
US-11758933-B2 High intensity sweeteners FIRMENICH INCORPORATED (US) 2023-09-19 — — US disclosed
WO-2023025549-A1 METHOD OF MITIGATING OFF-ODORS GIVAUDAN SA (CH) 2023-03-02 — — WO disclosed
EP-3368542-B1 HIGH INTENSITY SWEETENERS FIRMENICH INCORPORATED (US) 2022-06-22 — — EP disclosed
US-20120077728-A1 FLUID RESERVOIR HENKEL AG & CO. KGAA (DE) 2012-03-29 — — US disclosed
US-8093197-B2 Fluid reservoir HENKEL AG & CO. KGAA (DE) 2012-01-10 — — US disclosed
US-7884063-B2 perfume emulsions, for use in dryer; aromatherapy; spray containers, textile cleaning kits HENKEL AG & CO. KGAA (DE) 2011-02-08 — — US disclosed
US-20100047198-A1 Textile Scenting HENKEL AG & CO., KGAA (DE) 2010-02-25 — — US disclosed
US-20100022437-A1 Liquid Support HENKEL AG & CO. KGAA (DE) 2010-01-28 — — US disclosed
US-20090035337-A1 Fluid Reservoir HENKEL AG & CO. KGAA (DE) 2009-02-05 — — US disclosed
US-20080221003-A1 CONSUMER PRODUCTS HAVING VARYING ODOR PATTERNS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2008-09-11 — — US disclosed
US-20080207481-A1 CONSUMER PRODUCTS HAVING VARYING ODORS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2008-08-28 — — US disclosed
US-20080207476-A1 PARTICLES CONTAINING PERFUME HAVING IMPROVED FRAGRANCE PROPERTIES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2008-08-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240108040-A1 HIGH INTENSITY SWEETENERS TAS2R40, TAS2R60, TAS1R1 LMNA 4834/4885CYP3A4 4332/4885ALOX15 3088/4885
US-20090035337-A1 Fluid Reservoir CD44, VCL, PEF1 LMNA 2442/4885CYP3A4 4588/4885ALOX15 4369/4885
US-20100022437-A1 Liquid Support GYS2, GYS1, SLC18A1 LMNA 1210/4885CYP3A4 1726/4885ALOX15 594/4885
US-20120077728-A1 FLUID RESERVOIR CD44, VCL, PEF1 LMNA 2442/4885CYP3A4 4588/4885ALOX15 4369/4885
US-11758933-B2 High intensity sweeteners TAS2R40, TAS2R60, TAS1R1 LMNA 4834/4885CYP3A4 4332/4885ALOX15 3088/4885
US-20100047198-A1 Textile Scenting CUTA, LCT, LIPA LMNA 3811/4885CYP3A4 692/4885ALOX15 861/4885
US-20080207476-A1 PARTICLES CONTAINING PERFUME HAVING IMPROVED FRAGRANCE PROPERTIES DSC1, DSG1, PIEZO1 LMNA 2379/4885CYP3A4 1863/4885ALOX15 1395/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.